Ronald Blasberg

480 total citations
10 papers, 381 citations indexed

About

Ronald Blasberg is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ronald Blasberg has authored 10 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Ronald Blasberg's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (3 papers) and ATP Synthase and ATPases Research (2 papers). Ronald Blasberg is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (3 papers) and ATP Synthase and ATPases Research (2 papers). Ronald Blasberg collaborates with scholars based in United States, Netherlands and Canada. Ronald Blasberg's co-authors include Revathi Desai, Takamitsu Oku, Bradley J. Beattie, Juri G. Gelovani, Tadashi Miyagawa, Hisao Uehara, Inna Serganova, Ekaterina Moroz, Sean Burke and Sean Carlin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Ronald Blasberg

10 papers receiving 368 citations

Peers

Ronald Blasberg

RNMI

GENET

ONCOL

Selene Virk United States

Soumen Kahali United States

Jane Addis Canada

Laura I. Cárdenas-Navia United States

Joseph A. Eliason United States

Giulia Girolimetti Italy

Erika Gucciardo Finland

Charles Manhardt United States

Selene Virk United States

Ronald Blasberg

215 ×1.4

158 ×1.4

58 ×0.5

RNMI

201 ×2.2

GENET

68 ×0.9

ONCOL

Citations per year, relative to Ronald Blasberg Ronald Blasberg (= 1×) peers Selene Virk

Countries citing papers authored by Ronald Blasberg

Since Specialization

Citations

This map shows the geographic impact of Ronald Blasberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Blasberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Blasberg more than expected).

Fields of papers citing papers by Ronald Blasberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Blasberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Blasberg. The network helps show where Ronald Blasberg may publish in the future.

Co-authorship network of co-authors of Ronald Blasberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Blasberg. A scholar is included among the top collaborators of Ronald Blasberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Blasberg. Ronald Blasberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Verma, Svena, Rachana Maniyar, Myat Ko, et al.. (2021). 619 Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy. SHILAP Revista de lepidopterología. A649–A649. 2 indexed citations

Nayar, Utthara, Pin Lü, Rebecca Goldstein, et al.. (2013). Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood. 122(16). 2837–2847. 54 indexed citations

Zeglis, Brian M., Nagavarakishore Pillarsetty, Vadim Divilov, Ronald Blasberg, & Jason S. Lewis. (2011). The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), A PET radiotracer designed for the delineation of histone deacetylase expression in cancer. Nuclear Medicine and Biology. 38(5). 683–696. 16 indexed citations

Nayar, Utthara, Pin Lu, Jelena Vider, et al.. (2010). Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma. Infectious Agents and Cancer. 5(S1). 1 indexed citations

Moroz, Ekaterina, Sean Carlin, Katerina Dyomina, et al.. (2009). Real-Time Imaging of HIF-1α Stabilization and Degradation. PLoS ONE. 4(4). e5077–e5077. 92 indexed citations

Brader, Peter, Christopher C. Riedl, Yanghee Woo, et al.. (2007). Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Molecular Cancer Therapeutics. 6(11). 2900–2908. 23 indexed citations

Solit, David B., Elmer Santos, Christine A. Pratilas, et al.. (2007). 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition. Cancer Research. 67(23). 11463–11469. 48 indexed citations

Akhurst, Tim, Pat Zanzonico, Bradley J. Beattie, et al.. (2006). PET-based whole body dosimetry of 18F-FACBC, a tumor-avid non-metabolized amino acid: Initial results in patients. 47. 1 indexed citations

Miyagawa, Tadashi, Takamitsu Oku, Hisao Uehara, et al.. (1998). “Facilitated” Amino Acid Transport is Upregulated in Brain Tumors. Journal of Cerebral Blood Flow & Metabolism. 18(5). 500–509. 113 indexed citations

10.

Kolesnikov, Yuri, Revathi Joshi, Lawrence Koutcher, et al.. (1998). Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway.. PubMed. 12(1). 1–10. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact